Eli Lilly remains a top GARP opportunity, with Q3 results reinforcing its robust business growth and dominance in incretin ...

Eli Lilly reported strong earnings and raised guidance. Read more on what could be next for this biotech giant.

Eli Lilly shares rise as Q3 revenue jumps 54% to $17.6 billion, earnings top estimates, and analysts lift price targets on ...

Lilly predicts it will achieve an adjusted profit of between $23.00 and $23.70 per share this year, an increase on its ...

Eli Lilly stock rose early Thursday after the drugmaker easily topped third-quarter forecasts on the back of its two biggest ...

Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...

Wall Street eyed a US-China truce agreed by Trump and Xi, cooling hopes for a December rate cut and the next batch of Big Tech earnings.

Futures for the Dow Jones Industrial Average and other major stock indexes traded higher in premarket action Friday as Wall ...

However, as part of the deal, Avidity will first spin off its "early stage precision cardiology programs," for which "Avidity stockholders will also receive consideration for the separation of the ...

Asian shares have retreated after President Donald Trump's meeting with Chinese leader Xi Jinping. Trump said the meeting was ...

Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the ...

The mixed market mood from overseas weighed on the FTSE 100 at the open, although the premier index remains close to record highs. WPP failed to find any friends with another shar ...